It had continued to fuel controversies. Four years after its publication, the founding study of the IHU of Marseille on the use of hydroxychloroquine against Covid-19, signed by Professor Didier Raoult and seventeen of his colleagues, was officially invalidated. The publisher of the journal which published it in March 2020 made the announcement on Tuesday.
“Concerns have been raised” related to respect for “publication ethics,” explained Elsevier, the publisher of the scientific journal International journal of antimicrobial agentsin a long note justifying this retraction.
” Finally ! », savors Mathieu Molimard
The editor cites other concerns about “the appropriate conduct of research involving human participants, as well as concerns raised by three of the authors regarding the methodology and conclusions.”
” Finally ! We will now have to learn lessons and measure the consequences of this scientific and ethical misconduct,” said Professor Mathieu Molimard on the BlueSky social network. The head of department at Bordeaux University Hospital is the spearhead of the mobilization against Didier Raoult’s publications.
By clicking on“I accept”you accept the deposit of cookies by external services and will thus have access to the content of our partners.
More information on the Cookie management policy page
I accept
The former boss of the IHU of Marseille was sentenced, in October, to a two-year ban from medicine by the national disciplinary chamber of the order of doctors. This considered that he “did not exercise caution and promoted an insufficiently proven treatment”. Although he is retired, Didier Raoult appealed this sanction.
Coronavirus
